Skip to main content

ZNF432 Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-88692

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-88692

Key Product Details

Species Reactivity

Human

Applications

Validated:

Western Blot

Cited:

In vitro assay

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Specifications

Immunogen

The immunogen is a synthetic peptide directed towards the N-terminal region of human ZNF432. Peptide sequence: DERHSRICPENNEVDDHLQDHLENQRMLKSVEQYHEHNAFGNTASQTKSL The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for ZNF432 Antibody

Western Blot: ZNF432 Antibody [NBP2-88692]

Western Blot: ZNF432 Antibody [NBP2-88692]

Western Blot: ZNF432 Antibody [NBP2-88692] - WB Suggested Anti-ZNF432 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: Human Intestine

Applications for ZNF432 Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: ZNF432

ZNF432 may be involved in transcriptional regulation

Alternate Names

ZNF432 zinc finger protein 432

Gene Symbol

ZNF432

Additional ZNF432 Products

Product Documents for ZNF432 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for ZNF432 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...